Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190404043159N1
IRCT20190404043159N1
Not yet recruiting
Phase 2

The effect of duloxetine on symptoms and quality of life in patients with irritable bowel syndrome with moderate to severe symptoms

Esfahan University of Medical Sciences0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
40
Status
Not yet recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Men and women aged 18 to 65 years
  • •Diagnosis of irritable bowel syndrome by a gastroenterologist
  • •Moderate to severe symptoms
  • •Conscious consent to participate in the study
  • •Have a minimum literacy
  • •Absence of depressive disorders, bipolar disorder or psychotic disorders

Exclusion Criteria

  • •Diagnosis of any organic disease
  • •Failure to take medication regularly
  • •Failure to complete the questionnaire
  • •Severe side effects
  • •Patient request to leave the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
The effect of duloxetine in quality of life and symptoms of patients with irritable bowel syndrome (IBS)
IRCT20200928048862N1Iran University of Medical Sciences60
Not yet recruiting
Phase 2
the effect of duloxetine on theanxiety and depression of patients with diabetic neuropathyCondition 1: Effect of Duloxetine on the Mental State of Patients (Anxiety) with Diabetic Neuropathy. Condition 2: Effect of Duloxetine on the Mental State of Patients (Depression) with Diabetic Neuropathy.Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathyE08.43
IRCT20210725051977N2Islamic Azad University30
Recruiting
Not Applicable
Investigation on the effects of duloxetine on depressive symptoms and sleep disturbancesmajor depression
JPRN-UMIN000006386Department of Neuropsychiatry, Kagawa University School of Medicine30
Completed
Not Applicable
Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with Ritali
IRCT201110127462N2Tehran University of Medical Sciences40
Completed
Not Applicable
The effect of Deluxitine on the negative symptoms of schizophrenia
IRCT20191218045795N2Sanandaj University of Medical Sciences44